Posts by Nasrien E. Ibrahim, MD
Caution Needed When Interpreting BNP During Sacubitril/Valsartan Treatment
The effects of sacubitril/valsartan treatment on B-type natriuretic peptide vary in individual patients and according to the type of assay used.
New AI Model Predicts Acute Kidney Injury After Angiography
Cardiologists at Massachusetts General Hospital have developed a model using artificial intelligence that predicts acute kidney injury in patients undergoing coronary angiography.
Improving the Care of Heart Failure Patients Using the CASABLANCA Study
In this video, Nasrien Ibrahim, MD, discusses her work in identifying patients who are at risk for developing heart failure. She and her research team are using the CASABLANCA database to find biomarkers that could predict a patient's risk for heart failure.
#ACC19: A Twitter Roundup
Health care professionals at this year's American College of Cardiology Scientific Session and Expo discussed late-breaking research, innovative treatment approaches and new patient care guidelines. The conversations carried over from the podium and conference halls onto Twitter, with thousands of tweets.
Mass General at #ACC19
The American College of Cardiology's (ACC) Annual Scientific Session and Expo is a global exchange for cardiovascular scientists and clinicians to discuss and debate the latest science and information. Several cardiologists from Massachusetts General Hospital play important roles within the ACC before, during and after the annual symposium. A few of them share their perspectives on what excites them most about being an integral part of the ACC and ACC.19.
Women in Cardiology: A discussion on disparities
Despite many changes in the last two decades, women who work in Cardiology are still the minority. In this video, female cardiologists from the Massachusetts General Hospital Corrigan Minehan Heart Center talk about why it’s important to improve disparities in the field – for both their peers and patients.
Women and Men Differ in Response to Some Heart Failure Therapies
Women with heart failure are frequently undertreated, and even when they receive guideline-directed therapy, their treatment response and prognosis can differ from men's.
Physician Burnout and Why it is Important to Heal Outside of Work
Nasrien Ibrahim, MD, observes that physicians can lose themselves in their work and burnout. It is vital that doctors take care of themselves and engage in life outside of work so that they can be better role models for their patients.
#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More
Health care professionals at this year’s American Heart Association's Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter.
Endothelin-1 Is a Prognostic Marker in Patients Undergoing Coronary Angiography
By measuring endothelin-1 via a blood test, cardiologists may someday be able to determine which patients with cardiovascular disease are at highest risk of heart failure, myocardial infarction and death.
Poster: A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive PAD
Peripheral artery disease (PAD) is underdiagnosed and undertreated. A need exists for alternative means for evaluating PAD. A Mass General team describes a novel method to predict angiographically significant PAD.
#ACC18 Video: Scientific Session in Summary
Mass General physicians presented on the podium, moderated sessions and showcased posters over 50 times at the American College of Cardiology 2018 Scientific Sessions. Some of them answered the question: “What was the most interesting topic presented at this year’s Scientific Session?"
Novel Biomarkers for Heart Failure Management
Multibiomarker panels that include emerging novel biomarkers could surmount limitations of natriuretic peptides alone to improve personalized heart failure (HF) care.
Novel Noninvasive Scoring System Predicts Presence of Obstructive CAD
Noninvasive models to predict the presence of coronary artery disease may help reduce the societal burden of CAD.
Advances in Heart Failure Management
Conventional strategies and emerging novel therapies offer clinicians a management suite to offset the rising toll from heart failure.
I am a board certified cardiologist in the Advanced Heart Failure and Transplant Section within the Division of Cardiology at the Massachusetts General Hospital. I take care of patients with advanced heart failure, left ventricular assist devices, and heart transplants. I completed my internal medicine residency and general cardiology fellowship at the University of Cincinnati Medical Center in Cincinnati, OH. Next, I completed a fellowship in advanced heart failure and cardiac transplant at the University of Colorado in Denver, CO. Following that, I completed a fellowship in clinical research at the Massachusetts General Hospital. I am involved in several research studies in heart failure involving biomarkers and participate in several clinical trials.